Pyridazine derivatives and their use as therapeutic agents
A kind of medicine and compound technology, applied in the field of inhibitors of stearoyl-CoA desaturase
Inactive Publication Date: 2010-05-26
XENON PHARMACEUTICALS INC
View PDF5 Cites 0 Cited by
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
None of the known SCD inhibitor compounds are selective for SCD or delta-9 desaturases because they also inhibit other desaturases and enzymes
Method used
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View moreImage
Smart Image Click on the blue labels to locate them in the text.
Smart ImageViewing Examples
Examples
Experimental program
Comparison scheme
Effect test
preparation example 1
Embodiment 1
Embodiment 11
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More PUM
Login to View More Abstract
The invention relates to pyridazine derivatives and their use as therapeutic agents. Methods of treating an SCD-mediated disease or condition in a mammal, preferably a human, are disclosed, wherein the methods comprise administering to a mammal in need thereof a compound of formula (I), where x, y, W, V, R<2>, R<3>, R<4>, R<5>, R<6>, R<6a>, R<7>, R<7a>, R<8>, R<8a>, R<9> and R<9a> are defined herein. Pharmaceutical compositions comprising the compounds of formula (I) are also disclosed.
Description
This application is a divisional application of the patent application with the application number 200480021842.X, the application date is 29th, 2004, and the invention title is "pyridazine derivatives and their use as therapeutic agents". technical field The present invention relates generally to the field of inhibitors of stearoyl-CoA desaturases, such as pyridazine derivatives, and the use of such compounds in the treatment and / or prevention of various human diseases, including Those diseases mediated by acyl-CoA desaturase (SCD) enzymes, preferably SCD1 , especially those associated with elevated lipid levels, cardiovascular disease, diabetes, obesity, metabolic syndrome, etc. Background technique Acyl desaturases catalyze the formation of double bonds in fatty acids derived from dietary sources or de novo synthesis in the liver. Mammals synthesize at least three fatty acid desaturases with different chain length specificities that catalyze the addition of double bonds...
Claims
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More Application Information
Patent Timeline
Login to View More IPC IPC(8): C07D237/20C07D237/22A61K31/501A61P3/10A61P3/08A61P5/50A61P3/04A61P1/16A61P3/06A61P17/10A61P3/00A61K31/00A61K31/551C07D213/75C07D213/76C07D213/81
CPCA61K31/00A61K31/551C07D213/81C07D237/22C07D213/75A61K31/501C07D237/20C07D213/76A61P1/16A61P17/10A61P3/00A61P3/04A61P3/06A61P3/08A61P43/00A61P5/50A61P7/12A61P9/00A61P3/10
Inventor H·W·戈施文德V·柯杜穆鲁刘世峰R·卡姆博耶
Owner XENON PHARMACEUTICALS INC



